Subscribe to our Newsletters !!
How are viruses different from bacteria apex ? O
Pharmaceutical laboratories have been adopting imm
Bullet ants (Paraponera clavata) are famous for ha
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of The Magazine
Chennai, November 2020 – In March Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf acquires Koki’s centrifuge business, including the premium Himac brand. Since July 1st, 2020 Eppendorf Himac Technologies officially belongs to the Eppendorf Group. Since November 1st, 2020 Eppendorf India Pvt. Ltd. has been able to offer the Himac centrifuges in India.
The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research.
Effective November 1, 2020, Eppendorf India Pvt. Ltd. has been able to offer an even broader range of centrifuges with the high-quality floorstanding and high-speed centrifuges from Eppendorf Himac Technologies. With the new high-speed and large-volume floorstanding centrifuges, Eppendorf will be able to offer to all segments the right product. In addition, the modern Himac centrifuges offer a competitive advantage that customers value very highly.
“We are excited to acquire Koki’s centrifuge business and its premium Himac brand. These high-performance products are an ideal fit for Eppendorf’s centrifuges business and high-quality standards,” said Dr. Peter Fruhstorfer, Co-CEO of Eppendorf AG. “With this acquisition, Eppendorf will become a full-line provider of high-performance premium centrifuges on a global level. This gives us access to new customer groups and offers opportunities for further growth.” The centrifuge business is one of Eppendorf’s core businesses, Fruhstorfer continued, which will be sustainably strengthened by the acquisition.
More information will be available at https://ter.li/press
About Eppendorf
Eppendorf is a leading life science company that develops and sells instruments, consumables and services for liquid handling, sample handling and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and single-use bioreactor vessels complement the range of highest-quality premium products.Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics and at industrial laboratories performing process analysis, production and quality assurance.
Eppendorf was founded in Hamburg, Germany in 1945 and has about 4,000 employees worldwide. The company has subsidiaries in 26 countries and is represented in all its other important markets by distributors.
